on 25 Apr 2019
Last Applicant/ Owned by
Level 4
South Melbourne
AU
VIC 3205
Serial Number
79046715 filed on 12th Jun 2007
Registration Number
3612574 registered on 28th Apr 2009
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical and biotechnological preparations and substances for human medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; [ veterinary preparations and substances for animal medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; ] diagnostic preparations for medical use and reagents for medical use, namely, for diagnosis of human disease Read More
Pharmaceutical and biotechnological preparations and substances for human medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; [ veterinary preparations and substances for animal medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; ] diagnostic preparations for medical use and reagents for medical use, namely, for diagnosis of human diseases, such as cancer and autoimmune diseases; [ pharmaceutical and biotechnological preparations, namely, antibodies for the treatment of cancers and autoimmune diseases; ] pharmaceutical and biotechnological preparations, namely, antibody fragments and antibody conjugates for the treatment of cancers and autoimmune diseases; [ pharmaceutical and biotechnological preparations for the reconstruction and repair of antibodies for use in the field of cancers and autoimmune diseases; ] monoclonal antibodies for medical and veterinary use, namely, reagents for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; proteins for medical use, namely, for detecting antibodies; clinical medical reagents, namely, reagents for use in the development of monoclonal antibodies; proteins for medical use, namely, for binding antibodies; [ reagents for veterinary use, namely, reagents for the development of monoclonal antibodies; vaccines; vaccines against cancer, viral infection and bacterial infection, vaccines for human use; vaccine adjuvants; ] medical and veterinary diagnostic reagents, namely, reagents for use in tests for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; reagents for research purposes, namely, diagnostic reagents for medical research applications; cells for medical or clinical use, namely, recombinant human protein production cell lines; proteins for medical use in the field of recombinant DNA technology; biological reagents for medical purposes in the field of molecular biology
Scientific research and development, clinical research and scientific advisory and consultancy services all in relation to antibody production; drug discovery; [ research and development of vaccines, namely, vaccine screening; ] scientific research advisory services relating to diagnostic products for diagnosing cancers and autoimmune diseases; [ diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the field of science; ] medical research services; scientific research for medical purposes; pharmaceutical research services; scientific research advisory services comprising the preparation of reports relating to the performance and analysis of research and the outcomes of research in the field of pharmaceuticals and biotechnology; biochemical, chemical, microscopy, spectroscopy, physiological, histological, and electrical analysis of biological tissues for medical research; scientific research and development services for the production of antibodies; scientific research and development services for the discovery and development of proteins that bind to antibodies
No 79046715
No Service Mark
No 120776PLL001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
18th Jan 2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
25th Dec 2019 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
25th Apr 2019 | REGISTERED-SEC.71 ACCEPTED |
25th Apr 2019 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
09th Apr 2019 | TEAS SECTION 71 RECEIVED |
28th Apr 2018 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
29th Jun 2017 | INTERNATIONAL REGISTRATION RENEWED |
01st Jul 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
11th Sep 2015 | PARTIAL INVALIDATION PROCESSED BY THE IB |
19th Aug 2015 | INVALIDATION PROCESSED |